Navegar

Colección

Datos Estadísticas

Lista de

Adrenocorticotropic Hormone
30
"New insights in cushing disease treatment with focus on a derivative of vitamin A" (2018) Fuertes, M.;Tkatch, J.;Rosmino, J. (...)Arzt, E. Frontiers in Endocrinology. 9(MAY)
"Role of CREB on heme oxygenase-1 induction in adrenal cells: Involvement of the PI3K pathway" (2016) Astort, F.;Repetto, E.M.;Rocha-Viegas, L. (...)Cymeryng, C.B. Journal of Molecular Endocrinology. 57(2):113-124
"Effect of SOM230 (Pasireotide) on corticotropic cells: Action in dogs with Cushing's disease" (2011) Castillo, V.;Theodoropoulou, M.;Stalla, J. (...)Arzt, E. Neuroendocrinology. 94(2):124-136
"Pituitary tumors: Cell type-specific roles for BMP-4" (2010) Labeur, M.;Páez-Pereda, M.;Haedo, M. (...)Stalla, G.K. Molecular and Cellular Endocrinology. 326(1-2):85-88
"Induction of 5-aminolevulinate synthase by activators of steroid biosynthesis" (2007) Martini, C.N.; Romero, D.G.; Yanes, L.L.; Vila, M.d.C. Life Sciences. 81(1):19-25
"Characterization of L-arginine transport in adrenal cells: Effect of ACTH" (2006) Repetto, E.M.;Pannunzio, V.;Astort, F. (...)Cymeryng, C.B. American Journal of Physiology - Endocrinology and Metabolism. 291(2):E291-E297
"Characterization of L-arginine transport in adrenal cells: Effect of ACTH" (2006) Repetto, E.M.;Pannunzio, V.;Astort, F. (...)Cymeryng, C.B. American Journal of Physiology - Endocrinology and Metabolism. 291(2):E291-E297
"Bone morphogenetic protein-4 control of pituitary pathophysiology" (2006) Giacomini, D.;Páez-Pereda, M.;Theodoropoulou, M. (...)Arzt, E. Frontiers of Hormone Research. 35:22-31
"Retinoic acid as a novel medical therapy for Cushing's disease in dogs" (2006) Castillo, V.;Giacomini, D.;Páez-Pereda, M. (...)Arzt, E. Endocrinology. 147(9):4438-4444
"Signaling processes in tumoral neuroendocrine pituitary cells as potential targets for therapeutic drugs" (2005) Paez-Pereda, M.;Giacomini, D.;Echenique, C. (...)Arzt, E. Current Drug Targets: Immune, Endocrine and Metabolic Disorders. 5(3):259-267
"ACTH stimulates the release of alkaline phosphatase through Gi-mediated activation of a phospholipase C and the release of inositolphosphoglycan" (2004) Martini, C.N.; Vaena de Avalos, S.G.; del Carmen Vila, M. Molecular and Cellular Biochemistry. 258(1-2):191-199
"New perspectives in the treatment of cushing's syndrome" (2004) Labeur, M.; Arzt, E.; Stalla, G.K.; Péz-Pereda, M. Current Drug Targets: Immune, Endocrine and Metabolic Disorders. 4(4):335-342
"Increased splenocyte proliferative response and cytokine production in β-endorphin-deficient mice" (2002) Refojo, D.;Kovalovsky, D.;Young, J.I. (...)Arzt, E. Journal of Neuroimmunology. 131(1-2):126-134
"Classical and nonclassical 21-hydroxylase deficiency: A molecular study of Argentine patients" (2002) Dain, L.B.;Buzzalino, N.D.;Oneto, A. (...)Alba, L.G. Clinical Endocrinology. 56(2):239-245
"Extracellular matrix components regulate ACTH production and proliferation in corticotroph tumor cells" (2001) Kuchenbauer, F.;Hopfner, U.;Stalla, J. (...)Páez-Pereda, M. Molecular and Cellular Endocrinology. 175(1-2):141-148
"gp130 cytokine signaling in the pituitary gland: A paradigm for cytokine-neuro-endocrine pathways" (2001) Arzt, E. Journal of Clinical Investigation. 108(12):1729-1733
"Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas" (2000) Páez Pereda, M.;Lohrer, P.;Kovalovsky, D. (...)Arzt, E. Experimental and Clinical Endocrinology and Diabetes. 108(3):202-207
"Differential regulation of interleukin-1 receptor antagonist by proopiomelanocortin peptides adrenocorticotropic hormone and β-endorphin" (1999) Kovalovsky, D.;Pereda, M.P.;Stalla, G.K. (...)Arzt, E. NeuroImmunoModulation. 6(5):367-372
"Differential regulation of interleukin-1 receptor antagonist by proopiomelanocortin peptides adrenocorticotropic hormone and β-endorphin" (1999) Kovalovsky, D.;Pereda, M.P.;Stalla, G.K. (...)Arzt, E. NeuroImmunoModulation. 6(5):367-372
"Binding of 125I-prolactin to spermatozoa from normospermic and asthenospermic men" (1997) Luthy, I.A.;Mormandi, E.;Aszpis, S. (...)Calandra, R.S. Journal of Endocrinological Investigation. 20(11):635-639
"Regulation of the 11β-hydroxysteroid dehydrogenase in the rat adrenal: Decrease enzymatic activity induced by ACTH" (1997) Morita, H.;Cozza, E.N.;Zhou, M.-Y. (...)Gomez-Sanchez, C.E. Endocrine. 7(3):331-335
"Heme availability affects corticosterone and aldosterone biosynthesis in rat adrenal" (1997) Martini, C.N.;De Avalos, S.G.V.;Romero, D.G. (...)Vila, M.D.C. Steroids. 62(12):767-770
"In vitro effects of adenohypophysial hormones on rat pineal melatonin content and release" (1987) Vacas, M.I.;Sarmiento, M.I.K.;Pereyra, E.N. (...)Cardinali, D.P. Molecular and Cellular Endocrinology. 50(1-2):23-27
"Effect of median eminence lesions and hormonal replacement on the prolactin receptors in the adrenal Gland and langerhans islets from ovariectomized adult rats" (1985) Lüthy, I.A.;Tesone, M.;Oliveira-Filho, R.M. (...)Calandra, R.S. Journal of Receptors and Signal Transduction. 5(1):105-119
"Role of ACTH on the effect of medroxyprogesterone in brain stem serotonin" (1978) Izquierdo, J.A.;Savini, C.;Borghi, E. (...)Justel, E. Pharmacological Research Communications. 10(7):643-656